South Korea
· Delayed Price · Currency is KRW Biodyne Statistics
Total Valuation
Biodyne has a market cap or net worth of KRW 626.53 billion. The enterprise value is 606.48 billion.
| Market Cap | 626.53B |
| Enterprise Value | 606.48B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biodyne has 29.76 million shares outstanding. The number of shares has decreased by -30.18% in one year.
| Shares Outstanding | 29.76M |
| Shares Change (YoY) | -30.18% |
| Shares Change (QoQ) | -0.97% |
| Owned by Insiders (%) | 44.88% |
| Owned by Institutions (%) | 1.14% |
| Float | 16.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 146.97 |
| PB Ratio | 14.38 |
| P/FCF Ratio | 1,566.64 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -679.33 |
| EV / Sales | 144.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1,516.50 |
Financial Position
The company has a current ratio of 17.92, with a Debt / Equity ratio of 0.00.
| Current Ratio | 17.92 |
| Quick Ratio | 17.41 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.02 |
| Interest Coverage | -11,653.89 |
Financial Efficiency
Return on equity (ROE) is -2.05% and return on invested capital (ROIC) is -2.94%.
| Return on Equity (ROE) | -2.05% |
| Return on Assets (ROA) | -2.87% |
| Return on Capital (ROIC) | -2.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | 4.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.81% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -62.81% |
| 50-Day Moving Average | 16,014.20 |
| 200-Day Moving Average | 22,199.80 |
| Relative Strength Index (RSI) | 67.06 |
| Average Volume (20 Days) | 3,315,178 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biodyne had revenue of KRW 4.20 billion and -892.77 million in losses. Loss per share was -30.47.
| Revenue | 4.20B |
| Gross Profit | 921.10M |
| Operating Income | -2.05B |
| Pretax Income | -1.11B |
| Net Income | -892.77M |
| EBITDA | -402.02M |
| EBIT | -2.05B |
| Loss Per Share | -30.47 |
Balance Sheet
The company has 20.06 billion in cash and 6.83 million in debt, giving a net cash position of 20.05 billion or 673.64 per share.
| Cash & Cash Equivalents | 20.06B |
| Total Debt | 6.83M |
| Net Cash | 20.05B |
| Net Cash Per Share | 673.64 |
| Equity (Book Value) | 43.14B |
| Book Value Per Share | 1,463.39 |
| Working Capital | 20.80B |
Cash Flow
In the last 12 months, operating cash flow was 991.85 million and capital expenditures -591.93 million, giving a free cash flow of 399.92 million.
| Operating Cash Flow | 991.85M |
| Capital Expenditures | -591.93M |
| Free Cash Flow | 399.92M |
| FCF Per Share | 13.44 |
Margins
Gross margin is 21.95%, with operating and profit margins of -48.88% and -21.28%.
| Gross Margin | 21.95% |
| Operating Margin | -48.88% |
| Pretax Margin | -26.48% |
| Profit Margin | -21.28% |
| EBITDA Margin | -9.58% |
| EBIT Margin | -48.88% |
| FCF Margin | 9.53% |
Dividends & Yields
Biodyne does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 30.18% |
| Shareholder Yield | 30.18% |
| Earnings Yield | -0.14% |
| FCF Yield | 0.06% |
Stock Splits
The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Feb 28, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Biodyne has an Altman Z-Score of 161.32.
| Altman Z-Score | 161.32 |
| Piotroski F-Score | n/a |